Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CHCHD2P1 (Coiled-coil-helix-coiled-coil-helix domain containing 2 pseudogene 1) is a noncoding processed pseudogene located in the human genome. It is a retrocopy derived from the functional parental gene CHCHD2, which encodes a mitochondrial protein involved in metabolism, apoptosis, and neurodegenerative diseases. Unlike its parental gene, CHCHD2P1 does not produce a functional protein product and is not validated as playing a biological or pathological role in human cells. Pseudogenes in general can impact gene expression and cellular function indirectly, but such effects remain speculative for CHCHD2P1, with no specific evidence in the literature that it confers gene regulatory function, disease association, or is targeted by pharmacologic agents.
None. There are no drugs or biologics acting on CHCHD2P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil-helix-coiled-coil-helix domain containing 2 pseudogene 1 (CHCHD2P1).